Parabolic Drugs Limited reported earnings results for the fourth quarter and full year ended March 31, 2019. For the quarter, the company reported net loss after tax from continuing operations of INR 94.3 million against INR 146.9 million a year ago. Basic LPS was INR 1.52 against INR 2.37 a year ago. Diluted LPS was INR 6.69 against INR 9.21 a year ago. For the year, the company reported total revenue from operations of INR 180.8 million against INR 726.0 million a year ago. Net loss after tax from continuing operations was INR 414.0 million against INR 570.0 million a year ago. Basic LPS was INR 1.40 against INR 2.37 a year ago. Diluted LPS was INR 6.69 against INR 9.21 a year ago.